Literature DB >> 1449514

Inhibition of growth of human leukaemia 60 cells by S-2-hydroxyacylglutathiones and monoethyl ester derivatives.

J D Clelland1, R E Allen, P J Thornalley.   

Abstract

S-2-Hydroxyacylglutathione derivatives were found to induce growth arrest and toxicity in human leukaemia 60 cells in culture. S-D-Lactoylglutathione was the most effective with a median inhibitory concentration IC50 of 82 microM (95% C.I. 65-105 microM). No similar toxicity was induced by reduced glutathione and/or the corresponding aldonic acid (500 microM) in human leukaemia 60 cells, nor by S-D-lactoylglutathione (500 microM) in mature human neutrophils under the same culture conditions. Monoethyl ester derivatives of the S-2-hydroxyacylglutathiones were prepared and also induced growth arrest and toxicity but were less effective than the corresponding unesterified compounds. S-2-Hydroxyacylglutathione derivatives also inhibited the incorporation of [3H]thymidine into DNA early in the development of toxicity: for S-D-lactoylglutathione, the median inhibitory concentration was 74 microM (95% C.I. 47-116 microM). The mechanism of the inhibition of human leukaemia cell growth by S-D-lactoylglutathione and other S-2-hydroxyacylglutathione derivatives is unknown but appears to be mediated by the inhibition of DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1449514     DOI: 10.1016/0006-2952(92)90097-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  Facile synthesis of (R)N-2-hydroxyacyl-L-cysteine derivatives: (R)N-2-hydroxyacyl transfer from enzymatically-synthesized (R)S-2-hydroxyacylglutathione derivatives to L-cysteine.

Authors:  A Adesida; L G Edwards; P J Thornalley
Journal:  Amino Acids       Date:  1995-06       Impact factor: 3.520

Review 2.  Metabolic Shades of S-D-Lactoylglutathione.

Authors:  Miklós Péter Kalapos; Cinzia Antognelli; Lidia de Bari
Journal:  Antioxidants (Basel)       Date:  2022-05-20

3.  Novel glyoxalase-I inhibitors possessing a "zinc-binding feature" as potential anticancer agents.

Authors:  Qosay A Al-Balas; Mohammad A Hassan; Nizar A Al-Shar'i; Nizar M Mhaidat; Ammar M Almaaytah; Fatima M Al-Mahasneh; Israa H Isawi
Journal:  Drug Des Devel Ther       Date:  2016-08-17       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.